Intuitive Surgical, US46120E6023

Wall Street Zen downgrades Intuitive Surgical stock to Hold

Published on 10/05/2026 at 12:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 18.40 percent to USD 2.89 billion. Intuitive Surgical stock was EUR 348.85 on October 5, 2026 versus EUR 347.90.

Schwarzweiß-Reportagefoto eines Chirurgen an der Konsole während einer robotergestützten Operation
Dokumentarische Schwarzweiß-Reportage aus dem OP-Saal illustriert Intuitive Surgical Inc. (US46120E6023) und den Arbeitsalltag der Chirurgie-Robotik, Illustration mit AI erstellt.

Intuitive Surgical stock (ISIN US46120E6023) was trading at EUR 348.85 at Lang & Schwarz on October 5, 2026 at 12:34 p.m. CEST, up 0.27 percent from the prior close of EUR 347.90. As MarketBeat reported on September 20, 2026, Wall Street Zen downgraded Intuitive Surgical from Buy to Hold.

Analyst caution meets strong growth

The downgrade contrasts with Intuitive Surgical's latest operating performance. In the second quarter of 2026, revenue reached USD 2.89 billion, an 18.40 percent increase from the same period a year earlier, according to Yahoo Finance.

MarketBeat reported adjusted earnings per share of USD 2.80 for that quarter against a USD 2.48 consensus estimate. Revenue also exceeded the USD 2.83 billion estimate cited in the same report, giving the company a quantified earnings and sales cushion despite the later rating change.

Upcoming results set the next test

The next scheduled reporting date is October 20, 2026, according to Yahoo Finance. That report will give investors a fresh check on procedure growth, demand for the da Vinci platform and the pace of international expansion.

Intuitive Surgical's investor materials describe the company as a Nasdaq-listed developer of robotic-assisted, minimally invasive surgery systems, led by the da Vinci platform and supplemented by the Ion endoluminal system, according to Intuitive Surgical. The business therefore combines system placements with recurring instruments, accessories and service revenue, a structure that helps explain why quarterly revenue growth remains central to the stock discussion.

Stock remains below its yearly high

Intuitive Surgical had a market capitalization of USD 138.5 billion and a 52-week range of USD 328.57 to USD 603.88 as of October 2, 2026. The Lang & Schwarz euro quote converts to a level within that reported home-market range, while the modest daily change leaves the September rating decision and the October earnings date as the clearest reference points for the next trading phase.

The further course of trading is shown by the continuously updated real-time quote of Intuitive Surgical stock.

Intuitive Surgical stock at a glance

  • Company: Intuitive Surgical, Inc.
  • ISIN: US46120E6023
  • Ticker: ISRG
  • Primary exchange: Nasdaq
  • Price Lang & Schwarz (as of October 5, 2026, 12:34 p.m. CEST): EUR 348.85
  • Change versus prior close: plus 0.27 percent
  • Prior close Lang & Schwarz (October 2, 2026): EUR 347.90
  • Market capitalization: USD 138.5 billion (as of October 2, 2026)
  • 52-week range: USD 328.57-603.88 (as of October 2, 2026)
  • Sector / Industry: Healthcare / Medical Instruments and Supplies
  • Next earnings date: October 20, 2026

More news and analyses on Intuitive Surgical stock

Disclaimer...

en | US46120E6023 | INTUITIVE SURGICAL | boerse | 70232341 | bgmi